CollPlant Biotechnologies (CLGN) Other Non-Current Liabilities (2019 - 2021)
CollPlant Biotechnologies (CLGN) posted Other Non-Current Liabilities of -$28000.0 for Q4 2021, down 200.0% on a QoQ basis from $28000.0 in Q4 2020, and down 200.0% year-over-year from $28000.0 in Q4 2020.
CollPlant Biotechnologies (CLGN) Other Non-Current Liabilities (2019 - 2021) Analysis & Trends
CollPlant Biotechnologies' Other Non-Current Liabilities history runs 3 years deep, the most recent figure standing at -$28000.0 for Q4 2021.
- Quarterly Other Non-Current Liabilities fell 200.0% year-over-year to -$28000.0 in Q4 2021, while the trailing twelve-month figure through Dec 2021 was -$28000.0 (down 200.0% YoY) and the FY2021 annual result came in at -$28000.0, down 200.0% from the prior year.
- Other Non-Current Liabilities was -$28000.0 for Q4 2021 at CollPlant Biotechnologies, down from $28000.0 in the prior quarter.
- Across five years, Other Non-Current Liabilities topped out at $68000.0 in Q4 2019 and bottomed at -$28000.0 in Q4 2021.
- A 3-year average of $22666.7 and a median of $28000.0 in 2020 frame the typical range for Other Non-Current Liabilities.
- Annual changes were most pronounced in 2020 — Other Non-Current Liabilities sank 58.82% — and 2021, when it plunged 200.0%.
- CollPlant Biotechnologies' Other Non-Current Liabilities stood at $68000.0 in 2019, then sank by 58.82% to $28000.0 in 2020, then plunged by 200.0% to -$28000.0 in 2021.
- Business Quant data shows CLGN's Other Non-Current Liabilities at -$28000.0 in Q4 2021, $28000.0 in Q4 2020, and $68000.0 in Q4 2019.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - |
| 10 | CollPlant Biotechnologies | 4.63 Mn | 4.63 Mn | -243,000.00 |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2021 | -28,000.00 |
| Dec 31, 2020 | 28,000.00 |
| Dec 31, 2019 | 68,000.00 |